tiprankstipranks
Elicio Therapeutics (ELTX)
NASDAQ:ELTX
Holding ELTX?
Track your performance easily

Elicio Therapeutics (ELTX) Financial Statements

196 Followers

Elicio Therapeutics Financial Overview

Elicio Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.11; its P/E ratio is -1.20; Elicio Therapeutics is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is $-0.88. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -18.84M$ -7.23M$ -11.21M$ -10.66M$ -7.56M
EBITDA$ -18.56M$ -6.95M$ -10.90M$ -10.39M$ -7.05M
Net Income Common Stockholders$ -18.84M$ -7.23M$ -11.83M$ -10.66M$ -7.56M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 26.02M$ 3.40M$ 11.90M$ 14.84M$ 21.68M
Total Assets$ 38.39M$ 15.75M$ 24.48M$ 30.99M$ 37.62M
Total Debt$ 6.21M$ 6.42M$ 6.67M$ 7.15M$ 7.40M
Net Debt$ -19.80M$ 3.02M$ -5.23M$ -7.69M$ -14.28M
Total Liabilities$ 57.37M$ 17.40M$ 19.61M$ 17.70M$ 14.06M
Stockholders Equity$ -18.99M$ -1.65M$ 4.87M$ 13.29M$ 23.56M
Cash Flow-
Free Cash Flow$ -7.27M$ -8.97M$ -12.12M$ -5.23M$ -9.45M
Operating Cash Flow$ -7.27M$ -8.93M$ -12.12M$ -5.18M$ -9.47M
Investing Cash Flow-$ -42.00K$ 3.00K$ -45.00K$ 30.00K
Financing Cash Flow$ 30.75M$ 316.00K$ 11.02M$ 59.00K$ 21.51M
Currency in USD

Elicio Therapeutics Earnings and Revenue History

Elicio Therapeutics Debt to Assets

Elicio Therapeutics Cash Flow

Elicio Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis